Real world study of short term efficacy, safety, and tolerability of canagliflozin 100 mg initiation in type 2 diabetes mellitus patients during hot humid Indian summer
Publication date: January–February 2021Source: Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 15, Issue 1Author(s): Debmalya Sanyal, Anirban Majumder, Sujoy Ghosh, Kaushik Pandit
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
More News: Canagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | India Health | Invokana | Metabolic Syndrome | Study